文献速递细菌感染、耐药与抗菌药物医院感染防控

摩洛哥新生儿重症监护病房中同时产NDM-1和VIM-2的铜绿假单胞菌所致新生儿脓毒症

Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
PubMed 文献 · J Antimicrob Chemother · 2024-01-01

研究对摩洛哥一家新生儿重症监护病房分离的极端耐药铜绿假单胞菌O82J1进行分子机制分析,该菌同时产NDM-1和VIM-2两种金属β-内酰胺酶,仅对黏菌素和阿普霉素敏感,属于ST773高风险克隆。作者指出该菌对头孢地尔和ATM/AVI(氨曲南/阿维巴坦)也耐药,治疗选择极为有限,令人担忧。

要点

  • O82J1同时产NDM-1和VIM-2金属β-内酰胺酶,仅对黏菌素和阿普霉素敏感。
  • 该菌属ST773高风险克隆,blaVIM-2位于IncP-2 465-kb质粒,blaNDM-1位于染色体整合接合元件。
  • 检出23个耐药基因,包括blaPER-1超广谱β-内酰胺酶基因和16S-rRNA甲基转移酶基因rmtB。

核心结论

  • 在新生儿重症监护病房分离出表达多种碳青霉烯酶的极端耐药铜绿假单胞菌令人高度担忧,因治疗选择减少,仅依赖黏菌素(不推荐用于新生儿)和阿普霉素(尚未获批用于人体治疗)。
  • 该菌对头孢地尔和ATM/AVI耐药进一步加剧担忧,这两种新型最后防线抗生素推荐用于治疗革兰阴性菌感染,尤其是成人极端耐药铜绿假单胞菌感染。

研究设计与样本

  • 对摩洛哥一家新生儿重症监护病房分离的极端耐药铜绿假单胞菌菌株O82J1进行分子机制研究。
  • 采用MALDI-TOF-MS鉴定菌株,进行Carba NP试验、NG Carba5免疫层析检测以及纸片扩散法和微量肉汤法抗菌药物敏感性试验。
  • 使用Illumina和MinION技术进行全基因组测序,并利用基因组流行病学中心提供的不同软件包预测耐药组、序列型和质粒类型。

主要发现

  • O82J1同时表达blaNDM-1和blaVIM-2两种金属β-内酰胺酶,仅对黏菌素和阿普霉素敏感。
  • 该菌属于ST773,为全球频繁报道的高风险铜绿假单胞菌克隆。
  • blaVIM-2基因位于IncP-2 465-kb质粒上,由整合子携带;blaNDM-1基因位于染色体上,嵌入整合接合元件中,该元件可能是其获得来源。
  • 共检出23个抗菌药物耐药基因,包括blaPER-1超广谱β-内酰胺酶基因和16S-rRNA甲基转移酶基因rmtB。

临床怎么用

  • 作者指出,新生儿重症监护病房出现表达多种碳青霉烯酶的极端耐药铜绿假单胞菌分离株令人高度担忧,因治疗选择减少,仅依赖黏菌素(不推荐用于新生儿)和阿普霉素(尚未获批用于人体治疗)。
  • 作者指出,该菌对头孢地尔和ATM/AVI耐药进一步加剧担忧,这两种新型最后防线抗生素推荐用于治疗革兰阴性菌感染,尤其是成人极端耐药铜绿假单胞菌感染。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbapenem-resistant Pseudomonas aeruginosa are being increasingly described worldwide. Here, we investigated the molecular mechanisms underlying carbapenem resistance in an extremely drug-resistant P. aeruginosa isolate from a neonatal intensive care unit in Morocco. MATERIALS AND METHODS: P. aeruginosa strain O82J1 was identified using MALDI-TOF-MS. Carba NP, immunochromatographic assay NG Carba5 and antimicrobial susceptibility testing using disc diffusion and microbroth were performed. Whole-genome sequencing using the Illumina and MinION technologies and different software packages available at the Center of Genomic Epidemiology were used to predict the resistome, sequence type and plasmid types. RESULTS: P. aeruginosa O82J1 co-expressed two metallo-β-lactamases, blaNDM-1 and blaVIM-2, and was susceptible to colistin and apramycin only. It belonged to ST773 that is frequently reported worldwide as a high-risk P. aeruginosa clone. The blaVIM-2 gene was integron-borne on a IncP-2 465-kb plasmid, whereas the blaNDM-1 gene was chromosomally encoded and embedded in an integrative conjugative element, probably at the origin of its acquisition. A total of 23 antimicrobial resistance genes were detected including a blaPER-1 ESBL gene, and an 16S-rRNA methyltransferase gene rmtB. CONCLUSIONS: The isolation of XDR P. aeruginosa isolates expressing several carbapenemases in a neonatal intensive care unit is of great concern due to the reduced treatment options, relying only on colistin, but not recommended in neonates, and apramycin, not yet approved for human therapy. Concerns were further elevated due to the resistance to cefiderocol and ATM/AVI, two novel and last-resort antibiotics recommended to treat infections caused by Gram-negative bacteria, particularly XDR P. aeruginosa in adults.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Daaboul D, Osman M, Kassem II, et al. Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco. J Antimicrob Chemother. 2024. PMID: 38804143. doi:10.1093/jac/dkae153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。